Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00680134 · ClinicalTrials.gov registry record · Phase 2
Safety and Efficacy Evaluation of Topically Applied AN2690 Solutions for Subjects With Onychomycosis
A Phase 2 study, sponsored by Pfizer.
- Completed
- Registry status
- Phase 2
- Development phase
- 60
- Enrollment target
NCT00680134 is a Phase 2 study that has completed, run by Pfizer. The registered enrollment target is 60 participants.
The verdict
NCT00680134, a Phase 2 study, has completed, sponsored by Pfizer.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 60 participants
- Enrollment target
Study Summary
The purpose of the study is to determine the safety and efficacy of 1% and 5% AN2690 solutions in the treatment of distal, subungual onychomycosis of the great toenail.
Interventions
- DRUG AN2690
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2006-06-30 |
| Est. Completion | 2007-08-31 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00680134
The ClinicalTrials.gov registry entry for NCT00680134 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Pfizer, which has 1,845 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which AN2690 is the first listed.
NCT00680134 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00680134 about?
NCT00680134 is a clinical study titled "Safety and Efficacy Evaluation of Topically Applied AN2690 Solutions for Subjects With Onychomycosis". The purpose of the study is to determine the safety and efficacy of 1% and 5% AN2690 solutions in the treatment of distal, subungual onychomycosis of the great toenail.
What is the current status of trial NCT00680134?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 60 participants. The study started on 2006-06-30. Estimated completion is 2007-08-31.
What interventions are being tested in trial NCT00680134?
The interventions under investigation include: AN2690 (DRUG).
Who is sponsoring clinical trial NCT00680134?
This trial is sponsored by Pfizer, which has 1,845 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.